Golden Week For Daiichi: Damages Due From Ranbaxy Brothers

In what seems like some consolation for Daiichi Sankyo after its disastrous acquisition of Ranbaxy Laboratories and subsequent divestment of the Indian company, arbitration proceedings in Singapore against the Singh brothers of Ranbaxy have gone the Japanese firm's way.

More from Focus On Asia

More from Scrip